Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOCUREX INC (BOCX) -- Ignore unavailable to you. Want to Upgrade?

To: scion who wrote (18)	3/11/2003 11:56:47 AM
From: scion	Respond to of 21

Search term: RECAF Word Mark RECAF Goods and Services (CANCELLED) IC 030. US 046. G & S: SUGAR-SIZED PACKETS CONTAINING CAFFEINE WHICH MAY BE ADDED TO BEVERAGES SUCH AS COFFEE. FIRST USE: 19861201. FIRST USE IN COMMERCE: 19861201 Search term: Histo-RECAF Sorry, No results were found for your query. Search term: Cryo-RECAF Sorry, No results were found for your query. Search term: Serum-RECAF Sorry, No results were found for your query. tess2.uspto.gov The U.S. patent covers 17 claims, which include the technologies used in the Company's Histo-RECAF(tm) and Cryo-RECAF(tm) kits as well as in the Serum-RECAF(tm) kits to be released for cancer diagnosis on blood samples. The patent also covers other in-vitro applications for diagnosis, screening and follow-up of cancer and leukemia. In-vivo RECAF(tm) applications, such as cancer imaging, therapy and vaccination remain pending under a continuation in part of the original application. finance.lycos.com